Moors & Cabot, Inc.
- SEC CIK
- 0001607239
- Latest filing
- Aug 10, 2026
SRNE holding history
Sorrento Therapeutics, Inc. in every 13F filed by Moors & Cabot, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SRNE overviewAll 13F holders of SRNEFull Q2 2026 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 0 | $0 | 0.0% | −56,500−100.0% | Sold out | Holders |
| Q4 2022 | 56,500 | $50.1K | <0.1% | −2,000−3.4% | Reduced | Holders |
| Q3 2022 | 58,500 | $92.0K | <0.1% | −3,000−4.9% | Reduced | Holders |
| Q2 2022 | 61,500 | $124.0K | <0.1% | −1,000−1.6% | Reduced | Holders |
| Q1 2022 | 62,500 | $146.0K | <0.1% | +50,750+431.9% | Added | Holders |
| Q4 2021 | 11,750 | $55.0K | <0.1% | +11,750 | New | Holders |